Related Experiment Video
Updated: Jul 13, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
Maja Schlittler1, Peter P Pramstaller1, Alessandra Rossini1
1Eurac Research, Institute for Biomedicine (Affiliated to the University of Lübeck), 39100 Bolzano, Italy.
Insights
Hypertrophic cardiomyopathy (HCM), an inherited heart condition, involves cardiomyocyte hypertrophy and fibrosis. This review explores fibrosis promotion, fibroblast roles, and TGF-β signaling in HCM pathophysiology.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and a leading cause of sudden cardiac death in young individuals.
- Genetic mutations in cardiac sarcomere proteins are frequent causes of HCM.
- HCM is characterized by cardiomyocyte hypertrophy and myocardial fibrosis, impacting cardiac function.
Purpose of the Study:
- To review the latest evidence on the mechanisms promoting cardiac fibrosis in HCM.
- To elucidate the role of cardiac fibroblasts and their interaction with cardiomyocytes.
- To summarize findings on profibrotic genes and genetic/non-genetic factors in HCM pathophysiology.
Main Methods:
- Literature review of recent evidence on cardiac fibrosis in HCM.
- Analysis of the role of cardiac fibroblasts and their activation pathways.
- Summary of genetic and non-genetic factors contributing to HCM.
Main Results:
- Cardiac fibrosis, excessive deposition of collagen I and III, adversely affects heart function.
- The TGF-β pathway is a primary regulator of extracellular matrix turnover and fibroblast activation.
- New profibrotic genes and contributing factors to HCM are identified.
Conclusions:
- Understanding fibrosis promotion, fibroblast activation, and TGF-β signaling is crucial for HCM.
- Identifying genetic and non-genetic factors advances knowledge of HCM pathophysiology.
- This review synthesizes current knowledge on HCM, focusing on fibrotic mechanisms.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and the leading cause of sudden cardiac death in young people. Mutations in genes that encode structural proteins of the cardiac sarcomere are the more frequent genetic cause of HCM. The disease is characterized by cardiomyocyte hypertrophy and myocardial fibrosis, which is defined as the excessive deposition of extracellular matrix proteins, mainly collagen I and III, in the myocardium. The development of fibrotic tissue in the heart adversely affects cardiac function. In this review, we discuss the latest evidence on how cardiac fibrosis is promoted, the role of cardiac fibroblasts, their interaction with cardiomyocytes, and their activation via the TGF-β pathway, the primary intracellular signalling pathway regulating extracellular matrix turnover. Finally, we summarize new findings on profibrotic genes as well as genetic and non-genetic factors involved in the pathophysiology of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Introduction to Fibroblasts
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...

